X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-01-16 | QMCO | Quantum Corp /de/ | Lerner James J | Pres, CEO | S - Sale | $35.68 | -2,511 | 107,804 | -2% | -$89,592 | ||||||
2025-01-16 | QMCO | Quantum Corp /de/ | Spanjaard Henk Jan | Chief Revenue Officer | S - Sale | $35.68 | -935 | 14,903 | -6% | -$33,361 | ||||||
| M | 2025-01-15 | NYC | American Strategic Investment Co. | Schorsch Nicholas S | 10% | P - Purchase | $9.16 | +4,101 | 1,486,412 | 0% | +$37,551 | |||||
2025-01-16 | QMCO | Quantum Corp /de/ | Gianella Kenneth P. | CFO | S - Sale | $35.68 | -1,487 | 33,681 | -4% | -$53,056 | ||||||
| M | 2024-11-08 | QMCO | Quantum Corp /de/ | Cabrera Brian E | SVP Chief Admin Ofcr, Secy | S - Sale | $31.71 | -2,287 | 27,940 | -8% | -$72,512 | |||||
| M | 2025-01-15 | PNRG | Primeenergy Resources Corp | Hurt Clint | Dir | S - Sale | $214.69 | -3,834 | 131,942 | -3% | -$823,123 | |||||
| A | 2024-11-08 | QMCO | Quantum Corp /de/ | Nash Laura A. | Chief Accounting Officer | S - Sale | $4.43 | -328 | 11,788 | -3% | -$1,453 | |||||
| A | 2024-11-08 | QMCO | Quantum Corp /de/ | Lerner James J | Pres, CEO | S - Sale | $4.43 | -3,681 | 110,315 | -3% | -$16,307 | |||||
| A | 2024-11-08 | QMCO | Quantum Corp /de/ | Spanjaard Henk Jan | Chief Revenue Officer | S - Sale | $4.43 | -218 | 15,838 | -1% | -$966 | |||||
| A | 2024-11-08 | QMCO | Quantum Corp /de/ | Gianella Kenneth P. | CFO | S - Sale | $4.43 | -1,332 | 35,168 | -4% | -$5,901 | |||||
2025-01-17 | ADAP | Adaptimmune Therapeutics Plc | Norry Elliot | Chief Medical Officer | S - Sale | $0.58 | -5,584 | 7,510 | -43% | -$3,243 | ||||||
| A | 2024-11-08 | QMCO | Quantum Corp /de/ | Cabrera Brian E | SVP Chief Admin Ofcr, Secy | S - Sale | $4.43 | -2,118 | 30,227 | -7% | -$9,383 | |||||
2025-01-17 | ADAP | Adaptimmune Therapeutics Plc | Lunger John | Chief Patient Supply Officer | S - Sale | $0.58 | -5,584 | 7,510 | -43% | -$3,243 | ||||||
2025-01-17 | ADAP | Adaptimmune Therapeutics Plc | Bertrand William C Jr | COO | S - Sale | $0.58 | -5,584 | 7,510 | -43% | -$3,243 | ||||||
2025-01-17 | ADAP | Adaptimmune Therapeutics Plc | Rawcliffe Adrian | CEO | S - Sale | $0.58 | -30,601 | 44,327 | -41% | -$17,773 | ||||||
| M | 2025-01-15 | COMP | Compass, Inc. | Reffkin Robert L. | COB, CEO | S - Sale | $6.42 | -183,778 | 9,785,399 | -2% | -$1,179,060 | |||||
| M | 2025-01-15 | SKYH | Sky Harbour Group Corp | Boston Omaha Corp | 10% | S - Sale | $11.27 | -40,625 | 12,332,781 | 0% | -$457,879 | |||||
2025-01-15 | HCAT | Health Catalyst, Inc. | Llewelyn Linda | Chief People Officer | S - Sale | $5.80 | -6,442 | 92,260 | -7% | -$37,348 | ||||||
| D | 2025-01-15 | RDDT | Reddit, Inc. | Huffman Steve Ladd | CEO, Pres, 10% | S - Sale+OE | $172.76 | -124,408 | 614,394 | -17% | -$21,492,095 | |||||
| D | 2025-01-16 | IONS | Ionis Pharmaceuticals Inc | Swayze Eric | EVP Research | S - Sale+OE | $32.84 | -7,176 | 45,854 | -14% | -$235,678 | |||||
| D | 2025-01-16 | IONS | Ionis Pharmaceuticals Inc | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | S - Sale+OE | $32.79 | -6,523 | 58,508 | -10% | -$213,889 | |||||
| D | 2025-01-16 | IONS | Ionis Pharmaceuticals Inc | O'Neil Patrick R. | EVP CLO, GC | S - Sale+OE | $32.83 | -7,360 | 61,203 | -11% | -$241,629 | |||||
| D | 2025-01-16 | IONS | Ionis Pharmaceuticals Inc | Monia Brett P | CEO | S - Sale+OE | $32.63 | -33,445 | 207,396 | -14% | -$1,091,444 | |||||
| D | 2025-01-16 | IONS | Ionis Pharmaceuticals Inc | Hougen Elizabeth L | EVP, Finance, CFO | S - Sale+OE | $32.81 | -8,870 | 107,885 | -8% | -$290,989 | |||||
| D | 2025-01-16 | IONS | Ionis Pharmaceuticals Inc | Geary Richard S | EVP, Chief Development Officer | S - Sale+OE | $32.86 | -7,072 | 96,663 | -7% | -$232,407 | |||||
| D | 2025-01-16 | IONS | Ionis Pharmaceuticals Inc | Devers Shannon L. | EVP, Chief HR Ofc | S - Sale+OE | $32.78 | -4,267 | 15,937 | -21% | -$139,855 | |||||
| D | 2025-01-16 | IONS | Ionis Pharmaceuticals Inc | Birchler Brian | EVP, Corp, Development Ops | S - Sale+OE | $32.70 | -5,400 | 55,051 | -9% | -$176,580 | |||||
| D | 2025-01-16 | IONS | Ionis Pharmaceuticals Inc | Bennett C Frank | EVP, Chief Scientific Officer | S - Sale+OE | $32.90 | -6,752 | 90,866 | -7% | -$222,114 | |||||
| D | 2025-01-16 | IONS | Ionis Pharmaceuticals Inc | Baroldi Joseph | EVP, Chief Business Officer | S - Sale+OE | $32.70 | -4,430 | 28,088 | -14% | -$144,861 | |||||
2025-01-15 | FRGE | Forge Global Holdings, Inc. | Rodriques Kelly | CEO | S - Sale | $0.80 | -50,000 | 10,385,764 | 0% | -$40,205 | ||||||
| D | 2025-01-16 | MRSN | Mersana Therapeutics, Inc. | Mandelia Ashish | VP, Chief Accounting Officer | S - Sale+OE | $0.58 | -3,554 | 57,519 | -6% | -$2,061 | |||||
| D | 2025-01-16 | MRSN | Mersana Therapeutics, Inc. | Protopapas Anna | Dir | S - Sale+OE | $0.58 | -8,637 | 480,548 | -2% | -$5,009 | |||||
| D | 2025-01-16 | MRSN | Mersana Therapeutics, Inc. | Lowinger Timothy B | SVP, Chief Sci., Tech. Officer | S - Sale+OE | $0.58 | -8,048 | 257,673 | -3% | -$4,668 | |||||
| D | 2025-01-16 | MRSN | Mersana Therapeutics, Inc. | Huber Martin H. Jr. | Pres, CEO | S - Sale+OE | $0.58 | -4,514 | 122,875 | -4% | -$2,618 | |||||
| D | 2025-01-16 | MRSN | Mersana Therapeutics, Inc. | Deschuytner Brian | SVP, COO, CFO | S - Sale+OE | $0.58 | -8,470 | 121,393 | -7% | -$4,913 | |||||
| D | 2025-01-16 | MRSN | Mersana Therapeutics, Inc. | Carvajal Alejandra | SVP, GC | S - Sale+OE | $0.58 | -5,096 | 78,296 | -6% | -$2,956 | |||||
| D | 2025-01-16 | MRSN | Mersana Therapeutics, Inc. | Bala Mohan | SVP, Chief Development Officer | S - Sale+OE | $0.58 | -5,939 | 68,872 | -8% | -$3,445 | |||||
2025-01-17 | MDGL | Madrigal Pharmaceuticals, Inc. | Kelley Shannon T | GC | S - Sale | $273.41 | -277 | 7,705 | -3% | -$75,735 | ||||||
| M | 2025-01-15 | RXST | Rxsight, Inc. | Corley Jesse Anderson | Dir | P - Purchase | $31.15 | +3,210 | 541,580 | +1% | +$100,004 | |||||
2025-01-15 | KTOS | Kratos Defense & Security Solutions, Inc. | Mendoza Marie | SVP, GC | S - Sale | $33.30 | -1,500 | 61,782 | -2% | -$49,950 | ||||||
2025-01-17 | MDGL | Madrigal Pharmaceuticals, Inc. | Waltermire Robert E. | SVP, Chief Pharma Dev. | S - Sale | $273.41 | -442 | 5,058 | -8% | -$120,847 | ||||||
2025-01-17 | MDGL | Madrigal Pharmaceuticals, Inc. | Taub Rebecca | Pres, R, D,, CMO | S - Sale | $273.41 | -1,689 | 1,112,850 | 0% | -$461,789 | ||||||
2025-01-15 | OSTX | Os Therapies Inc | Auerbach Shalom | 10% | S - Sale | $6.74 | -16,720 | 2,554,582 | -1% | -$112,609 | ||||||
| D | 2025-01-15 | ZM | Zoom Communications, Inc. | Chadwick Jonathan | Dir | S - Sale+OE | $80.33 | -25,000 | 1,514 | -94% | -$2,008,195 | |||||
| M | 2025-01-15 | ONTF | On24 Inc. | Vattuone Steven | CFO | S - Sale | $6.50 | -1,522 | 542,864 | 0% | -$9,896 | |||||
2025-01-15 | ONTF | On24 Inc. | Trempont Dominique | Dir | S - Sale | $6.40 | -4,250 | 258,850 | -2% | -$27,188 | ||||||
2025-01-15 | PNRG | Primeenergy Resources Corp | De Rothschild Robert | 10% | S - Sale | $215.03 | -2,311 | 259,011 | -1% | -$496,943 | ||||||
2025-01-15 | DBX | Dropbox, Inc. | Regan Timothy | CFO | S - Sale | $30.37 | -2,500 | 401,264 | -1% | -$75,936 | ||||||
2025-01-15 | GDDY | Godaddy Inc. | Chen Roger | COO | S - Sale | $200.57 | -1,000 | 183,632 | -1% | -$200,570 | ||||||
| M | 2024-07-02 | GDDY | Godaddy Inc. | McCaffrey Mark | CFO | S - Sale | $167.62 | -1,104 | 83,254 | -1% | -$185,049 | |||||
| M | 2025-01-15 | TEM | Tempus Ai, Inc. | Keywell Bradley A | 10% | S - Sale | $35.03 | -946,084 | 15,218,365 | -6% | -$33,136,702 | |||||
2025-01-15 | PHR | Phreesia, Inc. | Hoffman Allison C | GC, Secretary | S - Sale | $26.90 | -4,585 | 154,552 | -3% | -$123,320 | ||||||
| M | 2025-01-15 | SFM | Sprouts Farmers Market, Inc. | Sinclair Jack | CEO | S - Sale | $139.49 | -5,850 | 146,584 | -4% | -$816,018 | |||||
2025-01-15 | PHR | Phreesia, Inc. | Indig Chaim | CEO | S - Sale | $26.98 | -2,990 | 1,514,230 | 0% | -$80,674 | ||||||
2025-01-15 | PHR | Phreesia, Inc. | Vanduyn Amy Beth | SVP, HR | S - Sale | $26.98 | -604 | 115,029 | -1% | -$16,297 | ||||||
2025-01-15 | PHR | Phreesia, Inc. | Hui Yvonne | Principal Accounting Officer | S - Sale | $26.87 | -381 | 25,774 | -1% | -$10,237 | ||||||
2025-01-15 | PHR | Phreesia, Inc. | Linetsky David | SVP, Life Sciences | S - Sale | $26.98 | -1,946 | 246,116 | -1% | -$52,506 | ||||||
2025-01-15 | PHR | Phreesia, Inc. | Roberts Evan | COO | S - Sale | $26.98 | -1,785 | 768,208 | 0% | -$48,162 | ||||||
2025-01-15 | PHR | Phreesia, Inc. | Gandhi Balaji | CFO | S - Sale | $26.98 | -836 | 147,673 | -1% | -$22,556 | ||||||
| D | 2025-01-16 | SES | Ses Ai Corp | Nealis Jing | CFO | S - Sale+OE | $1.02 | -50,000 | 1,922,629 | -3% | -$51,000 | |||||
2025-01-15 | IGMS | Igm Biosciences, Inc. | Weber Steven | Principal Accounting Officer | S - Sale | $1.70 | -1,122 | 30,582 | -4% | -$1,907 | ||||||
| D | 2025-01-15 | BRZE | Braze, Inc. | Fernandez Phillip M | Dir | S - Sale+OE | $43.13 | -1,500 | 15,269 | -9% | -$64,695 | |||||
| DM | 2025-01-15 | ULCC | Frontier Group Holdings, Inc. | Biffle Barry | CEO | S - Sale+OE | $8.42 | -433,000 | 1,424,741 | -23% | -$3,644,920 | |||||
2025-01-17 | TEAM | Atlassian Corp | Bharadwaj Anutthara | Pres | S - Sale | $259.85 | -1,520 | 210,471 | -1% | -$394,972 | ||||||
2025-01-16 | PTGX | Protagonist Therapeutics, Inc | Molina Arturo Md | Chief Medical Officer | S - Sale | $0.00 | -3,640 | 83,892 | -4% | -$0 | ||||||
2025-01-17 | TEAM | Atlassian Corp | Farquhar Scott | Dir, 10% | S - Sale | $253.01 | -7,948 | 389,452 | -2% | -$2,010,941 | ||||||
2025-01-17 | TEAM | Atlassian Corp | Cannon-Brookes Michael | CEO, Co-Founder, 10% | S - Sale | $253.01 | -7,948 | 389,452 | -2% | -$2,010,942 | ||||||
| D | 2025-01-15 | HOOD | Robinhood Markets, Inc. | Bhatt Baiju | Dir | S - Sale+OE | $45.27 | -90,866 | 5,042 | -95% | -$4,113,888 | |||||
2025-01-16 | PTGX | Protagonist Therapeutics, Inc | Ali Asif | CFO | S - Sale | $0.00 | -3,918 | 62,821 | -6% | -$0 | ||||||
| M | 2025-01-15 | ILLR | Triller Group Inc. | Diamond Robert E. Jr. | Dir | S - Sale | $2.46 | -129,071 | 8,089,553 | -2% | -$317,937 | |||||
| DM | 2025-01-15 | IOT | Samsara Inc. | Biswas Sanjit | CHIEF EXECUTVE OFFICER, 10% | S - Sale+OE | $45.51 | -249,972 | 1,225,204 | -17% | -$11,375,144 | |||||
| M | 2025-01-16 | PDEX | Pro Dex Inc | Cabillot Raymond E | Dir, 10% | S - Sale | $44.75 | -8,313 | 344,683 | -2% | -$371,988 | |||||
| DM | 2025-01-15 | IOT | Samsara Inc. | Bicket John | See remarks, 10% | S - Sale+OE | $45.52 | -242,283 | 351,801 | -41% | -$11,028,703 | |||||
2025-01-15 | NKTX | Nkarta, Inc. | Shook David | See Remarks | S - Sale | $2.20 | -8,638 | 190,955 | -4% | -$19,004 | ||||||
2025-01-15 | NKTX | Nkarta, Inc. | Levin Alyssa | See Remarks | S - Sale | $2.20 | -5,838 | 102,662 | -5% | -$12,844 | ||||||
2025-01-15 | NKTX | Nkarta, Inc. | Brandenberger Ralph | Chief Technical Officer | S - Sale | $2.20 | -7,447 | 124,796 | -6% | -$16,383 | ||||||
| D | 2025-01-16 | EBAY | Ebay Inc | Priest Stephen J | SVP, CFO | S - Sale+OE | $64.93 | -1,033 | 65,080 | -2% | -$67,073 | |||||
| D | 2025-01-15 | CVCO | Cavco Industries Inc. | Blount Susan L | Dir | S - Sale+OE | $471.70 | -750 | 2,836 | -21% | -$353,775 | |||||
2025-01-15 | NKTX | Nkarta, Inc. | Hastings Paul J | CEO | S - Sale | $2.20 | -17,378 | 319,859 | -5% | -$38,232 | ||||||
2025-01-15 | NKTX | Nkarta, Inc. | Hager Alicia J. | GC | S - Sale | $2.20 | -9,584 | 146,735 | -6% | -$21,085 | ||||||
| M | 2025-01-15 | LWAY | Lifeway Foods, Inc. | Smolyansky Ludmila | Member of 10% owner group | S - Sale | $22.60 | -29,726 | 1,068,166 | -3% | -$671,675 | |||||
| M | 2025-01-15 | CF | Cf Industries Holdings, Inc. | Menzel Susan L | EVP, CHIEF ADMIN. OFFICER | S - Sale | $96.95 | -2,850 | 91,136 | -3% | -$276,300 | |||||
| D | 2025-01-16 | BE | Bloom Energy Corp | Soderberg Shawn Marie | See Remarks | S - Sale+OE | $23.42 | -1,639 | 567,771 | 0% | -$38,385 | |||||
2025-01-17 | ETD | Ethan Allen Interiors Inc | Kathwari M Farooq | COB, Pres, CEO, 10% | S - Sale | $28.67 | -10,700 | 1,770,222 | -1% | -$306,769 | ||||||
| D | 2025-01-16 | ML | Moneylion Inc. | Hong Timmie | Chief Product Officer | S - Sale+OE | $86.39 | -6,254 | 91,011 | -6% | -$540,279 | |||||
2025-01-17 | OPK | Opko Health, Inc. | Frost Phillip Md Et Al | CEO, COB, 10% | P - Purchase | $1.47 | +150,000 | 246,882,605 | 0% | +$220,425 | ||||||
2025-01-15 | COUR | Coursera, Inc. | Ng Andrew Y. | Dir | S - Sale | $8.67 | -25,000 | 7,246,671 | 0% | -$216,660 | ||||||
| M | 2025-01-15 | EXFY | Expensify, Inc. | Barrett David Michael | CEO | S - Sale | $3.44 | -86,584 | 2,332,492 | -4% | -$297,710 | |||||
| M | 2025-01-15 | JILL | J.Jill, Inc. | Spofford Claire | Pres, CEO | S - Sale | $26.55 | -10,000 | 127,205 | -7% | -$265,500 | |||||
| DM | 2025-01-15 | CNM | Core & Main, Inc. | Whittenburg Mark G | GC, Secretary | S - Sale+OE | $55.14 | -50,000 | 7,667 | -87% | -$2,756,793 | |||||
| D | 2025-01-15 | SG | Sweetgreen, Inc. | Reback Mitch | CFO | S - Sale+OE | $33.13 | -8,000 | 746,792 | -1% | -$265,072 | |||||
2025-01-16 | ISBA | Isabella Bank Corp | Bourland Jill | Dir | P - Purchase | $25.50 | +8 | 4,920 | 0% | +$200 | ||||||
2024-08-13 | ETN | Eaton Corp Plc | Thompson Dorothy C | Dir | S - Sale | $289.51 | -285 | 2,721 | -9% | -$82,510 | ||||||
2025-01-15 | ALHC | Alignment Healthcare, Inc. | Maroney Dawn Christine | Pres | S - Sale | $13.61 | -30,000 | 1,606,097 | -2% | -$408,384 | ||||||
2025-01-15 | NMZ | Nuveen Municipal High Income Opportunity Fund | Bank of America Corp /de/ | 10% | P - Purchase | $10.79 | +6 | 0 | -100% | +$65 | ||||||
2025-01-15 | NMZ | Nuveen Municipal High Income Opportunity Fund | Bank of America Corp /de/ | 10% | S - Sale | $10.94 | -6 | 0 | -100% | -$66 | ||||||
2025-01-15 | NAD | Nuveen Quality Municipal Income Fund | Bank of America Corp /de/ | 10% | P - Purchase | $11.71 | +800 | 0 | -100% | +$9,368 | ||||||
2025-01-15 | NAD | Nuveen Quality Municipal Income Fund | Bank of America Corp /de/ | 10% | S - Sale | $11.66 | -800 | 0 | -100% | -$9,328 | ||||||
| M | 2025-01-15 | DORM | Dorman Products, Inc. | Berman Steven L | Dir | S - Sale | $129.09 | -5,119 | 950,691 | -1% | -$660,801 | |||||
| D | 2025-01-15 | NUVL | Nuvalent, Inc. | Porter James Richard | Pres, CEO | S - Sale+OE | $75.99 | -27,000 | 249,062 | -10% | -$2,051,777 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |